Skip To Main Content
Vaibhav Patel on Muck Rack

Vaibhav Patel

As seen in: Cell Press, Pharmaphorum, Pharmaceutical Online, Bioprocess Online, Outsourced Pharma, Cell & Gene Therapy Insights, Biosimilar Development

Get in touch with Vaibhav

Contact Vaibhav, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Navigating analytical and regulatory hurdles in early-phase clinical cell therapy development

|
By Vaibhav Patel, “Patient safety
| Cell & Gene Therapy Insights Verified
Cell & Gene Therapy Insights 2025; 11(2), 377–380 DOI: 10.18609/cgti.2025.044 Abi Pinchbeck, Editor, Cell & Gene Therapy Insights, speaks to Vaibhav Patel, Director of Quality Assurance and Regulatory Affairs at the University of Minnesota, about the analytical and regulatory challenges of cell and gene therapies, particularly in early phase development.
Open in Who Shared Issue with article?

01.22.25 -- 11 Key Contributing Factors For Maintaining Sterility Assurance

|
By Yadnyesh Patel, Vaibhav Patel, Abigail Hisler, Jean-Sebastien Steffen
| Bioprocess Online Verified
Let Us Handle Your Buffer Preparation Thermo Fisher Scientific is here to support you with the buffer preparation in your manufacturing workflow. Leaving the non-core activities to us enables you to focus on the patient therapy development. Our capabilities cover off-the-shelf products like WFI, NaOH, NaCl, or EtOH, a library of the most frequently used buffers that are made-to-order, as well as fully customized buffers.
Open in Who Shared Issue with article?

01.16.25 -- Become A cGMP "Special Agent" With A License To Care

|
By ajaz Hussain, Yadnyesh Patel, Vaibhav Patel
| Biosimilar Development Verified
With a third wave of biologics patents expiring, the race is on to seize the booming opportunities in the fast-evolving biosimilars field. What’s driving the patent scramble? What hurdles in manufacturing, regulation, and market access must be cleared for biosimilars to thrive? And how are global industry leaders carving out strategies to dominate the market? Don’t miss Bioprocess Online Live happening February 4th.
Open in Who Shared Issue with article?
See all 16 articles